Performant Healthcare, Inc. (NASDAQ:PHLT - Get Free Report) has been assigned a consensus recommendation of "Hold" from the five analysts that are covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $7.8750.
Several research firms recently issued reports on PHLT. Wall Street Zen cut Performant Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 3rd. Citizens Jmp lowered shares of Performant Healthcare from a "strong-buy" rating to a "hold" rating in a report on Friday, August 1st. Craig Hallum lowered shares of Performant Healthcare from a "strong-buy" rating to a "hold" rating and set a $7.75 price objective for the company. in a report on Monday, August 4th. B. Riley lowered shares of Performant Healthcare from a "strong-buy" rating to a "hold" rating in a report on Monday, August 4th. Finally, Lake Street Capital lowered shares of Performant Healthcare from a "strong-buy" rating to a "hold" rating and set a $7.75 price objective for the company. in a report on Monday, August 4th.
Read Our Latest Report on Performant Healthcare
Performant Healthcare Trading Down 0.1%
Shares of NASDAQ:PHLT traded down $0.01 on Wednesday, reaching $7.62. 2,204,143 shares of the company traded hands, compared to its average volume of 1,528,633. The business's 50-day simple moving average is $4.16 and its 200 day simple moving average is $3.12. Performant Healthcare has a 52 week low of $2.17 and a 52 week high of $7.74. The stock has a market capitalization of $596.72 million, a P/E ratio of -95.25 and a beta of 0.41. The company has a current ratio of 2.56, a quick ratio of 2.56 and a debt-to-equity ratio of 0.10.
Performant Healthcare (NASDAQ:PHLT - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.04. Performant Healthcare had a negative return on equity of 6.68% and a negative net margin of 4.62%. The firm had revenue of $33.27 million for the quarter, compared to analysts' expectations of $29.92 million. As a group, equities analysts anticipate that Performant Healthcare will post -0.13 EPS for the current fiscal year.
Insider Buying and Selling
In other news, Director Lisa Im sold 180,867 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $3.25, for a total value of $587,817.75. Following the sale, the director directly owned 1,229,413 shares of the company's stock, valued at $3,995,592.25. The trade was a 12.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 9.20% of the stock is owned by company insiders.
Institutional Trading of Performant Healthcare
A number of hedge funds have recently made changes to their positions in the stock. Intech Investment Management LLC bought a new position in Performant Healthcare in the 2nd quarter valued at approximately $137,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in Performant Healthcare during the 2nd quarter valued at $57,000. ProShare Advisors LLC purchased a new stake in Performant Healthcare during the 2nd quarter valued at $58,000. Savant Capital LLC purchased a new stake in shares of Performant Healthcare in the 2nd quarter worth $444,000. Finally, Bailard Inc. purchased a new stake in shares of Performant Healthcare in the 2nd quarter worth $301,000. 77.15% of the stock is owned by institutional investors.
About Performant Healthcare
(
Get Free Report)
Performant Healthcare, Inc engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients.
Read More

Before you consider Performant Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Performant Healthcare wasn't on the list.
While Performant Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.